Address: C76, Balewadi, Pune, Maharashtra
“Aquaculture Healthcare Market, Size, Share, Opportunities Analysis, By Product (Drug, Vaccines, Medicated Feed additives), By Species (Fishes, Crustaceans), By Route of Administration (Oral, Injectable, Topical), and By Region regional forecast, 2020-2028.”
The global Aquaculture Healthcare market is anticipated to expand at a CAGR of 5.9% between 2020 and 2027 and earn around 1.2 US$ billion by 2028. The rise in demand for high-quality fish and increase in awareness about the benefits obtained by fish have an enhanced the market.
The rise in the incidences of protein and vitamin deficiency have positively impacted the market growth
Key trends of global Aquaculture Healthcare market
The vendor landscape of the global Aquaculture Healthcare market is expected to stay moderately fragmented as several players are competing against each other. Aquaculture Healthcare companies focus on making Collaborations merger and acquisition deals, and increasing market presence in emerging countries. Archer Daniels Midland Company, Benchmark PLC, Ceva Sante, DuPont, Elanco, Merck, Vetoquinol S.A., Virbac, Zeal Aqua, and Zoetis LLC are the key competitors of the Global Aquaculture Healthcare market
Table of Segmentation:
ATTRIBUTE | DETAILS |
Study Period | 2019-2028 |
Unit | Value (USD Billion) |
Market scope | By Product
· Drug · Vaccines · Medicated Feed additives |
By Species
· Fishes · Crustaceans |
|
By Route of Administration
· Oral · Injectable · Topical |
|
By Region
· North America (U.S., Canada, and Mexico) · Europe (U.K., France, Italy, Spain, Germany, Russia, and the Rest of Europe) · Asia-Pacific (China, India, Japan, Australia, and the Rest of Asia- Pacific) · South America, Middle East & Africa (Brazil, South Africa, UAE, and the Rest of the region) |